Supriya Lifescience’s Ambernath facility receives WHO-GMP certification for Inhalation Dosages Corporates · Oct 1, 2025
Supriya Lifescience shares surge 2% after inauguration of new API production facility Stock Market · Dec 18, 2024
Supriya Lifescience inaugurates Rs 125 crore Module E production block at Lote Parshuram, boosts capacity by 55% Corporates · Dec 17, 2024
Supriya Lifescience strengthens global presence with Brazil approval and atorvastatin patent filing Corporates · Dec 9, 2024
